Tocris Bioscience社 2014年11月新製品
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5335 | Angiotensin A | Potent endogenous vasoconstrictor peptide - derivative of angiotensin II (Cat. No. 1158) |
| 5315 | Rostafuroxin | Antihypertensive agent; Na+/K+ ATPase modulator |
| 5310 | ASP 3026 | Potent anaplastic lymphoma kinase (ALK) inhibitor |
| 5285 | ZLN 024 hydrochloride | Allosteric AMPK activator |
| 5283 | HLM 006474 | E2F transcription factor inhibitor |
| 5040 | SB 706504 | p38 MAPK inhibitor |
| 4518 | EPPTB | Trace amine 1 (TA1) receptor antagonist/inverse agonist |
| 5325 | Rosiglitazone | Potent and selective PPARγ agonist; antidiabetic agent. |
| 5313 | LY 315920 | Selective secreted phospholipase A2 (sPLA2) inhibitor |
| 5272 | MK 0677 | High affinity ghrelin receptor agonist |
| 5266 | BAZ2-ICR | Selective BAZ2 bromodomain inhibitor |
| 4958 | Eplivanserin hemifumarate | Potent and selective 5-HT2A antagonist |
| 5289 | OF 1 | Selective BRPF1B and BRPF2 bromodomain inhibitor |
| 5261 | Dimethylenastron | Inhibitor of mitotic motor kinesin Eg5 |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
